https://pubmed.ncbi.nlm.nih.gov/41388765/
Pancreatic cancer (PCA) is the third leading cause of cancer-related death in Europe. Despite recent therapeutic advances, patients experience rapid health...
third line therapytreatmentlandscapefirstquality
https://www.ajmc.com/view/comparison-between-guideline-preferred-and-nonpreferred-first-line-hiv-antiretroviral-therapy
Initiation of guideline-preferred first-line antiretroviral therapy (ART) was associated with better ART adherence and persistence and similar total healthcare...
first linecomparisonguidelinepreferredhiv
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2019.00701/full
Objectives: There is a lack of effective therapy for recurrent or metastatic salivary gland carcinoma. Androgen deprivation therapy has demonstrated efficac...
androgen deprivation therapyfirst linefrontiersvschemotherapy
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1238553/full
Background: Anlotinib showed encouraging anti-tumor activity in metastatic colorectal cancer (mCRC). This study was designed to assess the efficacy and safet...
frontiersefficacysafetyanlotinibplus
https://www.mdpi.com/2077-0383/13/7/1929
Diffuse large B-cell lymphoma (DLBCL) is the most prevalent subtype of lymphoma, comprising heterogeneous patient subgroups with distinctive biological and...
first line therapynew insightsdiffuselargeb
https://pubmed.ncbi.nlm.nih.gov/29615901/
Sunitinib is the most commonly prescribed drug for advanced renal cell carcinoma in the first-line setting and has been associated with multiple adverse events...
adjunct therapykidney cancerisoquercetinpatients
https://www.aidsmap.com/news/jul-2013/first-line-antiretroviral-therapy-has-improved-over-time-meta-analysis-shows
The effectiveness of initial antiretroviral treatment has improved markedly over the years, but many people still do not achieve full HIV suppression and a...
first lineantiretroviral therapymeta analysisimprovedtime